dr. garassino discusses recent pivotal immunotherapy findings in nsclc
Published 6 years ago • 116 plays • Length 1:36Download video MP4
Download video MP3
Similar videos
-
1:07
dr. garassino on immunotherapy in egfr-mutated lung cancer
-
1:53
dr. garassino discusses pros with durvalumab by pd-l1 expression in stage iii nsclc
-
1:34
dr. garassino on the pacific trial for nsclc
-
9:41
immunotherapy with antiangiogenics in nsclc
-
2:05
dr. garassino discusses promising findings with osimertinib for patients with nsclc and brain mets
-
1:59
dr. herbst on key immunotherapy findings in nsclc
-
1:31
dr. garassino on qol findings from the flaura study in nsclc
-
1:50
dr. west discusses latest immunotherapy findings in lung cancer
-
4:08
final thoughts on nsclc
-
0:49
dr. sabari on immunotherapy updates in small cell lung cancer
-
1:01
dr. winer discusses immunotherapy in gynecologic malignancies
-
1:04
dr. garon on immunotherapy in stage iii unresectable nsclc
-
1:30
dr. sabari discusses immunotherapy biomarkers in nsclc
-
5:00
implications for pembrolizumab in nsclc
-
1:39
pembrolizumab and epacadostat for nsclc: echo-306/keynote-715
-
1:22
dr. bauml on the use of immunotherapy in oligometastatic nsclc
-
1:25
dr. brahmer on chemoimmunotherapy in patients with nsclc
-
1:50
dr. levy discusses pembrolizumab in nsclc
-
1:54
dr. langer discusses the impact of targeted therapy in nsclc